Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Increases in use of methotrexate since the 1980s.

Sokka T.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S13-20. Epub 2010 Oct 28. Review.

PMID:
21044427
2.

Clinical trials to establish methotrexate as a therapy for rheumatoid arthritis.

Coury FF, Weinblatt ME.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S9-12. Epub 2010 Oct 28. Review.

PMID:
21044426
3.
4.

Methotrexate: from its introduction to non-oncologic therapeutics to anti-TNF-α.

Benedek TG.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S3-8. Epub 2010 Oct 28. Review.

PMID:
21044425
5.

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.

Singh JA, Hossain A, Tanjong Ghogomu E, Kotb A, Christensen R, Mudano AS, Maxwell LJ, Shah NP, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 May 13;(5):CD012183. doi: 10.1002/14651858.CD012183. Review.

PMID:
27175934
6.

Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.

Machado DA, Guzman RM, Xavier RM, Simon JA, Mele L, Pedersen R, Ferdousi T, Koenig AS, Kotak S, Vlahos B.

J Clin Rheumatol. 2014 Jan;20(1):25-33. doi: 10.1097/RHU.0000000000000055.

PMID:
24356474
7.

Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).

Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 Nov 17;11:CD012437. Review.

PMID:
27855242
8.

Methotrexate pharmacogenetics in rheumatoid arthritis.

Brinker RR, Ranganathan P.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S33-9. Epub 2010 Oct 28. Review.

PMID:
21044431
9.

Methotrexate in rheumatoid arthritis.

Swierkot J, Szechiński J.

Pharmacol Rep. 2006 Jul-Aug;58(4):473-92. Review.

10.

Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis.

Katchamart W, Trudeau J, Phumethum V, Bombardier C.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008495. doi: 10.1002/14651858.CD008495. Review.

PMID:
20393970
11.
14.
15.

The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.

Aletaha D, Smolen JS.

Rheumatology (Oxford). 2002 Dec;41(12):1367-74.

PMID:
12468815
16.

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Soliman MM, Ashcroft DM, Watson KD, Lunt M, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register..

Ann Rheum Dis. 2011 Apr;70(4):583-9. doi: 10.1136/ard.2010.139774. Epub 2011 Feb 17.

17.

Etanercept for the treatment of rheumatoid arthritis.

Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2013 May 31;(5):CD004525. doi: 10.1002/14651858.CD004525.pub2. Review.

PMID:
23728649
18.

[Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice].

La Montagna G, Tirri R, Vitello R, Malesci D, Buono R, Mennillo G, Valentini G.

Reumatismo. 2006 Oct-Dec;58(4):261-7. Italian.

19.

A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.

Ma MH, Kingsley GH, Scott DL.

Rheumatology (Oxford). 2010 Jan;49(1):91-8. doi: 10.1093/rheumatology/kep331. Epub 2009 Nov 16. Review.

PMID:
19917618
20.

The use of conventional disease-modifying anti-rheumatic drugs in established RA.

Jurgens MS, Jacobs JW, Bijlsma JW.

Best Pract Res Clin Rheumatol. 2011 Aug;25(4):523-33. doi: 10.1016/j.berh.2011.10.006. Review.

PMID:
22137922

Supplemental Content

Support Center